CV Sciences, Inc.
CVSI· OTC
Released Nov 13, 2025, after the close
10-Q filed Nov 13, 2025, 44 days after period end · 0001193125-25-280515
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Revenue | $3.26M | $3.87M | $4.09M | $3.75M |
| Net Income | -$382.00K | -$456.00K | -$447.00K | -$1.03M |
| EPS Diluted |
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR
| $0.00 |
| $0.00 |
| $0.00 |
| -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.